We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301. Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301.
MALVERN, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (โAnnovisโ or the โCompanyโ), a clinical-stage drug platform company developing novel therapies for...
MALVERN, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (โAnnovisโ or the โCompanyโ), a clinical-stage drug platform company developing novel therapies for...
MALVERN, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (โAnnovisโ or the โCompanyโ), a clinical-stage drug platform company developing novel therapies for...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.57 | 29.6226415094 | 5.3 | 7.26 | 4.79 | 759668 | 5.75623126 | CS |
4 | -4.81 | -41.1815068493 | 11.68 | 20 | 4.79 | 1071338 | 7.65527488 | CS |
12 | -3.69 | -34.9431818182 | 10.56 | 20 | 4.79 | 519633 | 8.49539455 | CS |
26 | 1.02 | 17.4358974359 | 5.85 | 22.49 | 4.79 | 408517 | 9.926706 | CS |
52 | -7.36 | -51.7217146873 | 14.23 | 22.49 | 4.79 | 224904 | 9.95641559 | CS |
156 | -20.13 | -74.5555555556 | 27 | 132 | 4.79 | 279718 | 40.81954832 | CS |
260 | -2.1175 | -23.5605006954 | 8.9875 | 132 | 2.418 | 275210 | 32.01146341 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions